TY - JOUR
T1 - Early origins of lung disease
T2 - towards an interdisciplinary approach
AU - Ubags, Niki D. J.
AU - Alcazar, Miguel A. Alejandre
AU - Kallapur, Suhas G.
AU - Knapp, Sylvia
AU - Lanone, Sophie
AU - Lloyd, Clare M.
AU - Morty, Rory E.
AU - Pattaroni, Celine
AU - Reynaert, Niki L.
AU - Rottier, Robbert J.
AU - Smits, Hermelijn H.
AU - Piters, Wouter A. A. de Steenhuijsen
AU - Strickland, Deborah H.
AU - Collins, Jennifer J. P.
N1 - Funding Information:
Support statement: This review is based on a Research Seminar funded by the European Respiratory Society. M.A. Alejandre Alcazar is supported by Deutsche Forschungsgemeinschaft (AL1632/2-1), Marga and Walter Boll Stiftung and Oskar Helene Heim Stiftung. S. Knapp is supported by the Austrian Science Fund (FWF) Special Research Program Chromatin Landscapes (L-Mac: F 6104-B21). R.E. Morty was supported by the Max Planck Society, the German Center for Lung Research and German Research Foundation (grants 390649896, 268555672, 284237345, 160966624 and 420759458). N.L. Reynaert is supported by the Lung Foundation Netherlands (6.1.16.088). J.J.P. Collins was supported by a Dirkje Postma Talent Award from the Lung Foundation Netherlands (11.1.16.152). Funding information for this article has been deposited with the Crossref Funder Registry.
Funding Information:
Conflict of interest: N.D.J. Ubags has nothing to disclose. M.A. Alejandre Alcazar reports grants from Deutsche Forschungsgemeinschaft, Marga and Walter Boll Stiftung and Stiftung Oskar-Helene-Heim, during the conduct of the study. S.G. Kallapur has nothing to disclose. S. Knapp reports grants from Austrian Science Fund, during the conduct of the study. S. Lanone has nothing to disclose. C.M. Lloyd has nothing to disclose. R.E. Morty has nothing to disclose. C. Pattaroni has nothing to disclose. N.L. Reynaert reports grants from Lung Foundation Netherlands, during the conduct of the study. R.J. Rottier has nothing to disclose. H.H. Smits has nothing to disclose. W.A.A. de Steenhuijsen Piters has nothing to disclose. D.H. Strickland has nothing to disclose. J.J.P. Collins reports grants from Lung Foundation Netherlands, during the conduct of the study.
Publisher Copyright:
© ERS 2020.
PY - 2020/9/30
Y1 - 2020/9/30
N2 - The prenatal and perinatal environments can have profound effects on the development of chronic inflammatory diseases. However, mechanistic insight into how the early-life microenvironment can impact upon development of the lung and immune system and consequent initiation and progression of respiratory diseases is still emerging. Recent studies investigating the developmental origins of lung diseases have started to delineate the effects of early-life changes in the lung, environmental exposures and immune maturation on the development of childhood and adult lung diseases. While the influencing factors have been described and studied in mostly animal models, it remains challenging to pinpoint exactly which factors and at which time point are detrimental in lung development leading to respiratory disease later in life. To advance our understanding of early origins of chronic lung disease and to allow for proper dissemination and application of this knowledge, we propose four major focus areas: 1) policy and education; 2) clinical assessment; 3) basic and translational research; and 4) infrastructure and tools, and discuss future directions for advancement. This review is a follow-up of the discussions at the European Respiratory Society Research Seminar "Early origins of lung disease: towards an interdisciplinary approach" (Lisbon, Portugal, November 2019).
AB - The prenatal and perinatal environments can have profound effects on the development of chronic inflammatory diseases. However, mechanistic insight into how the early-life microenvironment can impact upon development of the lung and immune system and consequent initiation and progression of respiratory diseases is still emerging. Recent studies investigating the developmental origins of lung diseases have started to delineate the effects of early-life changes in the lung, environmental exposures and immune maturation on the development of childhood and adult lung diseases. While the influencing factors have been described and studied in mostly animal models, it remains challenging to pinpoint exactly which factors and at which time point are detrimental in lung development leading to respiratory disease later in life. To advance our understanding of early origins of chronic lung disease and to allow for proper dissemination and application of this knowledge, we propose four major focus areas: 1) policy and education; 2) clinical assessment; 3) basic and translational research; and 4) infrastructure and tools, and discuss future directions for advancement. This review is a follow-up of the discussions at the European Respiratory Society Research Seminar "Early origins of lung disease: towards an interdisciplinary approach" (Lisbon, Portugal, November 2019).
KW - MESENCHYMAL STROMAL CELLS
KW - EARLY-LIFE EXPOSURES
KW - LONG-TERM PULMONARY
KW - A VIRUS-INFECTION
KW - NEONATAL HYPEROXIA
KW - ADULT MICE
KW - BRONCHOPULMONARY DYSPLASIA
KW - INCREASES SENSITIVITY
KW - CYTOKINE PRODUCTION
KW - IMMUNE DEVELOPMENT
U2 - 10.1183/16000617.0191-2020
DO - 10.1183/16000617.0191-2020
M3 - (Systematic) Review article
C2 - 33004528
SN - 0905-9180
VL - 29
JO - European Respiratory Review
JF - European Respiratory Review
IS - 157
M1 - 200191
ER -